Guidant, Medtronic bristle at ICDs (implantable cardioverter defibrillators) delay in US
This article was originally published in Clinica
Executive Summary
US ICD companies have denounced Medicare's plans to postpone a national coverage decision on the prophylactic use of implantable cardioverter defibrillators (ICDs) pending examination of data from the as-yet unpublished SCD-HeFT trial, sponsored by the National Heart Lung and Blood Institute.